Phenylarsine oxide interferes with the death inducing signaling complex and inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis

Experimental Cell Research

Volumn 315, Issue 14, 2009, Pages 2453-2462

  Sun, Xiao Ming ^a   Canda Sánchez, Ana ^a   Manjeri, Ganesh R ^a   Cohen, Gerald M ^a   Pinkoski, Michael J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Death inducing signaling complex; DISC; Phenylarsine oxide; TRAIL

Indexed keywords

ARSENOSOBENZENE; CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CELL MEMBRANE; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; DRUG EXPOSURE; DRUG TARGETING; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; MITOCHONDRIAL PERMEABILITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 67649198945     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.014     Document Type: Article

References (35)

1. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2 (2002) 420-430
2. Takeda K., Stagg J., Yagita H., Okumura K., and Smyth M.J. Targeting death-inducing receptors in cancer therapy. Oncogene 26 (2007) 3745-3757
3. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., and Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12 (2000) 599-609
4. Harper N., Farrow S.N., Kaptein A., Cohen G.M., and MacFarlane M. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases. J. Biol. Chem. 276 (2001) 34743-34752
5. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., and Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12 (2000) 611-620
6. Eramo A., Sargiacomo M., Ricci-Vitiani L., Todaro M., Stassi G., Messina C.G., Parolini I., Lotti F., Sette G., Peschle C., and De Maria R. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells. Eur. J. Immunol. 34 (2004) 1930-1940
7. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schutze S., Peter M.E., and Chan A.C. The role of receptor internalization in CD95 signaling. EMBO J. 25 (2006) 1009-1023
8. Atkinson E.A., Ostergaard H., Kane K., Pinkoski M.J., Caputo A., Olszowy M.W., and Bleackley R.C. A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J. Biol. Chem. 271 (1996) 5968-5971
9. Harper N., Hughes M., MacFarlane M., and Cohen G.M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278 (2003) 25534-25541
10. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
11. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
12. Kohlhaas S.L., Craxton A., Sun X.M., Pinkoski M.J., and Cohen G.M. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J. Biol. Chem. 282 (2007) 12831-12841
13. Austin C.D., Lawrence D.A., Peden A.A., Varfolomeev E.E., Totpal K., De Maziere A.M., Klumperman J., Arnott D., Pham V., Scheller R.H., and Ashkenazi A. Death-receptor activation halts clathrin-dependent endocytosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10283-10288
14. Tollefson A.E., Toth K., Doronin K., Kuppuswamy M., Doronina O.A., Lichtenstein D.L., Hermiston T.W., Smith C.A., and Wold W.S. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J. Virol. 75 (2001) 8875-8887
15. Webb J.E. Arsenicals. Enzyme Metab. Inhibitors 3 (1966) 595-793
16. Halestrap A.P., Woodfield K.Y., and Connern C.P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272 (1997) 3346-3354
17. McStay G.P., Clarke S.J., and Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J. 367 (2002) 541-548
18. Costantini P., Chernyak B.V., Petronilli V., and Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271 (1996) 6746-6751
19. Scorrano L., Petronilli V., Colonna R., Di Lisa F., and Bernardi P. Interactions of chloromethyltetramethylrosamine (Mitotracker Orange) with isolated mitochondria and intact cells. Ann. N.Y. Acad. Sci. 893 (1999) 391-395
20. Frost S.C., and Lane M.D. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260 (1985) 2646-2652
21. Garcia-Morales P., Minami Y., Luong E., Klausner R.D., and Samelson L.E. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9255-9259
22. Liao K., Hoffman R.D., and Lane M.D. Phosphotyrosyl turnover in insulin signaling. Characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J. Biol. Chem. 266 (1991) 6544-6553
23. Hertel C., Coulter S.J., and Perkins J.P. A comparison of catecholamine-induced internalization of beta-adrenergic receptors and receptor-mediated endocytosis of epidermal growth factor in human astrocytoma cells. Inhibition by phenylarsine oxide. J. Biol. Chem. 260 (1985) 12547-12553
24. Kaplan J., Ward D.M., and Wiley H.S. Phenylarsine oxide-induced increase in alveolar macrophage surface receptors: evidence for fusion of internal receptor pools with the cell surface. J. Cell. Biol. 101 (1985) 121-129
25. Sun X.M., Bratton S.B., Butterworth M., MacFarlane M., and Cohen G.M. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277 (2002) 11345-11351
26. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., and Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274 (1999) 5053-5060
27. MacFarlane M., Ahmad M., Srinivasula S.M., Fernandes-Alnemri T., Cohen G.M., and Alnemri E.S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272 (1997) 25417-25420
28. Bazan J.F. Emerging families of cytokines and receptors. Curr. Biol. 3 (1993) 603-606
29. Cha S.S., Sung B.J., Kim Y.A., Song Y.L., Kim H.J., Kim S., Lee M.S., and Oh B.H. Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity. J. Biol. Chem. 275 (2000) 31171-31177
30. Mongkolsapaya J., Grimes J.M., Chen N., Xu X.N., Stuart D.I., Jones E.Y., and Screaton G.R. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 6 (1999) 1048-1053
31. Wassenaar T.A., Quax W.J., and Mark A.E. The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study. Proteins 70 (2008) 333-343
32. Thomas L.R., Johnson R.L., Reed J.C., and Thorburn A. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation. J. Biol. Chem. 279 (2004) 52479-52486
33. Natoni A., MacFarlane M., Inoue S., Walewska R., Majid A., Knee D., Stover D.R., Dyer M.J., and Cohen G.M. TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2. Br. J. Haematol. 139 (2007) 568-577
34. MacFarlane M., Inoue S., Kohlhaas S.L., Majid A., Harper N., Kennedy D.B., Dyer M.J., and Cohen G.M. Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell. Death Differ. 12 (2005) 773-782
35. Zhang Y., and Zhang B. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol. Cancer Res. 6 (2008) 1861-1871